Dasiglucagon in a dual-hormone artificial pancreas system: Ph IIa start

Zealand began an open-label, crossover, U.S. Phase IIa trial to compare dasiglucagon in a dual-hormone artificial pancreas system vs. glucagon in 1-day periods in up to 20 patients. Earlier this year,...